Affinity-independent memory B cell origin of the early antibody-secreting cell response in naive individuals upon SARS-CoV-2 vaccination

Immunity. 2024 Sep 10;57(9):2191-2201.e5. doi: 10.1016/j.immuni.2024.07.023. Epub 2024 Aug 20.

Abstract

Memory B cells (MBCs) formed over the individual's lifetime constitute nearly half of the circulating B cell repertoire in humans. These pre-existing MBCs dominate recall responses to their cognate antigens, but how they respond to recognition of novel antigens is not well understood. Here, we tracked the origin and followed the differentiation paths of MBCs in the early anti-spike (S) response to mRNA vaccination in SARS-CoV-2-naive individuals on single-cell and monoclonal antibody levels. Pre-existing, highly mutated MBCs showed no signs of germinal center re-entry and rapidly developed into mature antibody-secreting cells (ASCs). By contrast, and despite similar levels of S reactivity, naive B cells showed strong signs of antibody affinity maturation before differentiating into MBCs and ASCs. Thus, pre-existing human MBCs differentiate into ASCs in response to novel antigens, but the quality of the humoral and cellular anti-S response improved through the clonal selection and affinity maturation of naive precursors.

Keywords: SARS-CoV-2; affinity maturation; germinal center; humoral immunity; mRNA vaccination; pre-existing memory B cells; somatic hypermutation.

MeSH terms

  • Adult
  • Antibodies, Monoclonal / immunology
  • Antibodies, Viral* / immunology
  • Antibody Affinity / immunology
  • Antibody-Producing Cells* / immunology
  • COVID-19 Vaccines* / immunology
  • COVID-19* / immunology
  • COVID-19* / prevention & control
  • Cell Differentiation / immunology
  • Female
  • Germinal Center / immunology
  • Humans
  • Immunologic Memory / immunology
  • Memory B Cells* / immunology
  • SARS-CoV-2* / immunology
  • Spike Glycoprotein, Coronavirus* / immunology
  • Vaccination

Substances

  • Antibodies, Viral
  • Spike Glycoprotein, Coronavirus
  • COVID-19 Vaccines
  • spike protein, SARS-CoV-2
  • Antibodies, Monoclonal